Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer

ClinicalTrials.gov ID: NCT00321685

Public ClinicalTrials.gov record NCT00321685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients With Locally Advanced Rectal Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial studies how well giving bevacizumab, radiation therapy, and combination chemotherapy works in treating patients who are undergoing surgery for locally advanced nonmetastatic rectal cancer. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some find tumor cells and kill them or carry tumor-killing substances to them. Others interfere with the ability of tumor cells to grow and spread. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs, such as capecitabine, may make tumor cells more sensitive to radiation therapy. Drugs used in chemotherapy, such as capecitabine, oxaliplatin, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving bevacizumab together with radiation therapy and combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving bevacizumab together with combination chemotherapy after surgery may kill any tumor cells that remain after surgery.

Study identification

NCT ID
NCT00321685
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
57 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 25, 2006 (Actual)
Primary completion
Aug 12, 2013 (Actual)
Completion
Feb 11, 2019 (Actual)
Last update posted
Mar 27, 2019

2006 – 2019

United States locations

U.S. sites
107
U.S. states
17
U.S. cities
69
Facility City State ZIP Site status
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 —
The Hospital of Central Connecticut New Britain Connecticut 06050 —
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 —
Atlanta VA Medical Center Decatur Georgia 30033 —
Medical Center of Central Georgia Macon Georgia 31201 —
Rush - Copley Medical Center Aurora Illinois 60504 —
MacNeal Hospital and Cancer Center Berwyn Illinois 60402 —
Hematology and Oncology Associates Chicago Illinois 60611 —
Northwestern University Chicago Illinois 60611 —
Jesse Brown Veterans Affairs Medical Center Chicago Illinois 60612 —
Mercy Hospital and Medical Center Chicago Illinois 60616 —
Swedish Covenant Hospital Chicago Illinois 60625 —
Presence Saint Joseph Hospital-Chicago Chicago Illinois 60657 —
Saint Anthony Memorial Hospital Effingham Illinois 62401 —
Hematology Oncology Associates of Illinois-Highland Park Highland Park Illinois 60035 —
Hinsdale Hematology Oncology Associates Incorporated Hinsdale Illinois 60521 —
Midwest Center for Hematology Oncology Joliet Illinois 60432 —
Joliet Oncology-Hematology Associates Limited Joliet Illinois 60435 —
NorthShore Hematology Oncology-Libertyville Libertyville Illinois 60048 —
Garneau, Stewart C MD (UIA Investigator) Moline Illinois 61265 —
Porubcin, Michael MD (UIA Investigator) Moline Illinois 61265 —
Sharis, Christine M MD (UIA Investigator) Moline Illinois 61265 —
Spector, David MD (UIA Investigator) Moline Illinois 61265 —
Stoffel, Thomas J MD (UIA Investigator) Moline Illinois 61265 —
Trinity Medical Center Moline Illinois 61265 —
Vigliotti, Antonio, P.G. M.D. (UIA Investigator) Moline Illinois 61265 —
DuPage Medical Group-Ogden Naperville Illinois 60563 —
Illinois Cancer Specialists-Niles Niles Illinois 60714 —
Edward H Kaplan MD and Associates Skokie Illinois 60076 —
Hematology Oncology Associates of Illinois - Skokie Skokie Illinois 60076 —
Carle Cancer Center Urbana Illinois 61801 —
Franciscan Saint Anthony Health-Michigan City Michigan City Indiana 46360 —
Constantinou, Costas L MD (UIA Investigator) Bettendorf Iowa 52722 —
Siouxland Regional Cancer Center Sioux City Iowa 51101 —
Mercy Medical Center-Sioux City Sioux City Iowa 51102 —
Saint Luke's Regional Medical Center Sioux City Iowa 51104 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Borgess Medical Center Kalamazoo Michigan 49048 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview-Southdale Hospital Edina Minnesota 55435 —
Unity Hospital Fridley Minnesota 55432 —
Hutchinson Area Health Care Hutchinson Minnesota 55350 —
Meeker County Memorial Hospital Litchfield Minnesota 55355 —
Minnesota Oncology Hematology PA-Maplewood Maplewood Minnesota 55109 —
Saint John's Hospital - Healtheast Maplewood Minnesota 55109 —
Abbott-Northwestern Hospital Minneapolis Minnesota 55407 —
Virginia Piper Cancer Institute Minneapolis Minnesota 55407 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
North Memorial Medical Health Center Robbinsdale Minnesota 55422 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota 55416 —
Regions Hospital Saint Paul Minnesota 55101 —
Saint Joseph's Hospital - Healtheast Saint Paul Minnesota 55102 —
United Hospital Saint Paul Minnesota 55102 —
Saint Francis Regional Medical Center Shakopee Minnesota 55379 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Minnesota Oncology Hematology PA-Woodbury Woodbury Minnesota 55125 —
Woodwinds Health Campus Woodbury Minnesota 55125 —
Nebraska Cancer Research Center Lincoln Nebraska 68510 —
Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Alegent Health Immanuel Medical Center Omaha Nebraska 68122 —
Alegent Health Bergan Mercy Medical Center Omaha Nebraska 68124 —
Creighton University Medical Center Omaha Nebraska 68131 —
Virtua Memorial Mount Holly New Jersey 08060 —
Sparta Cancer Treatment Center Sparta New Jersey 07871 —
Virtua Voorhees Voorhees Township New Jersey 08043 —
Inspira Medical Center Woodbury Woodbury New Jersey 08096 —
Montefiore Medical Center-Wakefield Campus The Bronx New York 10466 —
Montefiore Medical Center - Moses Campus The Bronx New York 10467 —
Summa Akron City Hospital/Cooper Cancer Center Akron Ohio 44304 —
Summa Barberton Hospital Barberton Ohio 44203 —
Mary Rutan Hospital Bellefontaine Ohio 43311 —
Adena Regional Medical Center Chillicothe Ohio 45601 —
Riverside Methodist Hospital Columbus Ohio 43214 —
Grant Medical Center Columbus Ohio 43215 —
Mount Carmel Health Center West Columbus Ohio 43222 —
Doctors Hospital Columbus Ohio 43228 —
Grady Memorial Hospital Delaware Ohio 43015 —
Fairfield Medical Center Lancaster Ohio 43130 —
Saint Rita's Medical Center Lima Ohio 45801 —
Marietta Memorial Hospital Marietta Ohio 45750 —
Licking Memorial Hospital Newark Ohio 43055 —
Springfield Regional Medical Center Springfield Ohio 45505 —
Saint Ann's Hospital Westerville Ohio 43081 —
Genesis Healthcare System Cancer Care Center Zanesville Ohio 43701 —
Natalie Warren Bryant Cancer Center at Saint Francis Tulsa Oklahoma 74136 —
Lehigh Valley Hospital-Cedar Crest Allentown Pennsylvania 18103 —
Mercy Fitzgerald Hospital Darby Pennsylvania 19023-1291 —
Pocono Medical Center East Stroudsburg Pennsylvania 18301 —
Ephrata Cancer Center Ephrata Pennsylvania 17522 —
Riddle Memorial Hospital Media Pennsylvania 19063 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Aria Health-Torresdale Campus Philadelphia Pennsylvania 19114 —
Einstein Medical Center Philadelphia Philadelphia Pennsylvania 19141 —
Hematology and Oncology Associates of North East Pennsylvania Scranton Pennsylvania 18508 —
Associates In Hematology Oncology PC-Upland Upland Pennsylvania 19013 —
Sanford Cancer Center Oncology Clinic Sioux Falls South Dakota 57104 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
Avera McKennan Hospital and University Health Center Sioux Falls South Dakota 57105 —
Medical X-Ray Center Sioux Falls South Dakota 57105 —
Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota 57117-5134 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00321685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00321685 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →